Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | VHL |
Variant | N78K |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | VHL N78K does not lie within any known functional domains of the Vhl protein (UniProt.org). N78K has been identified in sequencing studies (PMID: 23434146, PMID: 11921283, PMID: 38344974), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). |
Associated Drug Resistance | |
Category Variants Paths |
VHL mutant VHL N78K |
Transcript | NM_000551.4 |
gDNA | chr3:g.10142081T>G |
cDNA | c.234T>G |
Protein | p.N78K |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_198156.3 | chr3:g.10142081T>G | c.234T>G | p.N78K | RefSeq | GRCh38/hg38 |
NM_198156.2 | chr3:g.10142081T>G | c.234T>G | p.N78K | RefSeq | GRCh38/hg38 |
NM_000551.3 | chr3:g.10142081T>G | c.234T>G | p.N78K | RefSeq | GRCh38/hg38 |
NM_001354723.1 | chr3:g.10142081T>G | c.234T>G | p.N78K | RefSeq | GRCh38/hg38 |
NM_000551.4 | chr3:g.10142081T>G | c.234T>G | p.N78K | RefSeq | GRCh38/hg38 |
NM_001354723.2 | chr3:g.10142081T>G | c.234T>G | p.N78K | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
VHL N78K | clear cell renal cell carcinoma | predicted - sensitive | Belzutifan | Case Reports/Case Series | Actionable | In a clinical case study, a patient with metastatic clear cell renal cell carcinoma harboring VHL N78K responded to treatment with Welireg (belzutifan) as a second-line therapy (PMID: 38344974). | 38344974 |